Dr. Caforio, age 52, serves as chairman of Bristol-Myers Squibb’s Board of Directors. Caforio has been our Chief Executive Officer since May 2015. He was our Chief Executive Officer Designate from January to May 2015, our Chief Operating Officer from June 2014 to May 2015, and he served as Executive Vice President and Chief Commercial Officer from November 2013 to June 2014.

As CEO, Caforio has led the company’s focus on researching and developing transformational medicines, which includes a leading portfolio of immunotherapies that are fundamentally changing the way cancer is treated. Under his leadership, Bristol Myers Squibb is evolving its operating model, in order to increase speed and competitiveness.

With a background as a physician, Caforio has helped strengthen the company’s patient-focused culture — one driven by innovation, speed, accountability and passion. As a leader, he is focused on the business value of a company culture that promotes and rewards diversity and inclusion.

CEO, Chief Executive Officer (CEO), Boards of Directors, Global Development, Oncology, Pharmaceutical, Diversity, Inclusion, Medicine Technology, Science, Global Health, Cancer, TIME 100,